CrossRef An in-depth review of PPAR modulators as anti-diabetes therapeutics Aryan Jangra, Basuvan Babu, Selvaraj Divakar, Byran Gowramma, Saveri Rajan, Sonam Jangra, Vishnu Malakar Drug Metabolism Reviews.2025
It has approval from the FDA to help with weight loss and treating type 2 diabetes
Now that the FDA has announced that compounding pharmacies must stop the large-scale production of compounded versions of tirzepatide, obtaining your mediation may change in the following ways
Patients with dyslipidaemia requiring pharmacological treatment should continue statins as per NICE guidance (NG238)
Label the vial with compound, concentration and reconstitution date, store at 28C between assays
Tirzepatide: Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist